S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.04%) $0.926
USD/NOK
(-0.05%) $10.84
USD/GBP
(-0.11%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for ADiTx Therapeutics, Inc. [ADTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-04-02)

Expected move: +/- 16.30%

Last Updated28 Mar 2024 @ 16:00

11.84% $ 3.40


Warning: Undefined array key 1 in /home/getagraph/public_html/signalbox.php on line 10
SELL 64524 min ago

@ $4.00

Issued: 13 Feb 2024 @ 14:29


Return: -15.00%


Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues...

Stats
Today's Volume 187 848
Average Volume 587 391
Market Cap 6.67M
EPS $-48.77 ( 2023-11-14 )
Next earnings date ( $-17.14 ) 2024-04-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.280
ATR14 $0.0340 (1.00%)
Insider Trading
Date Person Action Amount type
2023-11-08 Runge Jeffrey W. Buy 470 Options (right to buy)
2023-11-08 Albanna Rowena Buy 4 702 Options (right to buy)
2023-11-08 Nelson Charles Athle Buy 470 Options (right to buy)
2023-11-08 Albanna Amro A. Buy 9 404 Options (right to buy)
2023-11-08 Pankovcin Corinne Buy 4 702 Options (right to buy)
INSIDER POWER
26.25
Last 84 transactions
Buy: 1 934 500 | Sell: 1 185 103

Volume Correlation

Long: 0.57 (weak)
Short: 0.81 (strong)
Signal:(58.939) Same movement expected

ADiTx Therapeutics, Inc. Correlation

10 Most Positive Correlations
OGI0.974
BNGO0.971
VERB0.971
CNXC0.968
IMBI0.965
NESR0.965
MRIN0.964
WATT0.963
MMAT0.962
DISH0.961
10 Most Negative Correlations
MSDA-0.971
ADAL-0.966
TIOAU-0.961
TIOA-0.961
BRIV-0.96
LEGA-0.959
ZING-0.959
SKYA-0.958
CRZN-0.957
VLAT-0.957

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ADiTx Therapeutics, Inc. Correlation - Currency/Commodity

The country flag 0.83
( strong )
The country flag 0.82
( strong )
The country flag 0.00
( neutral )
The country flag 0.66
( moderate )
The country flag 0.57
( weak )
The country flag -0.63
( weak negative )

ADiTx Therapeutics, Inc. Financials

Annual 2022
Revenue: $933 715
Gross Profit: $166 936 (17.88 %)
EPS: $-608.04
Q3 2023
Revenue: $124 486
Gross Profit: $17 564.00 (14.11 %)
EPS: $-47.95
Q2 2023
Revenue: $220 978
Gross Profit: $35 240.00 (15.95 %)
EPS: $-36.79
Q1 2023
Revenue: $218 415
Gross Profit: $40 106.00 (18.36 %)
EPS: $-55.98

Financial Reports:

No articles found.

ADiTx Therapeutics, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators